Highlights the risk of serotonin syndrome when combining serotomimetic agents with monoamine oxidase inhibitors.
No takes yet. Share an insight, caveat, or question.
May warrant caution combining serotomimetic agents with MAOIs; single case report leaves open broader incidence and prevention strategies.
Bodner et al. (1995) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: